A Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session

Dear Colorado Life Sciences Community,

Colorado BioScience Association builds a collaborative, pro-innovation environment for life sciences innovation. Through our Policy + Advocacy efforts, we work at the state and federal level to advance priorities that support our ecosystem and the patients we serve.

The 2021 state legislative session ended last week. CBSA worked tirelessly this session to protect programs that advance innovation and mitigate the impact of legislation that could harm our ecosystem. I want to especially thank the CBSA team, policy committee members, lobbyists, and coalition partners who worked to amend Senate Bill 175, the prescription drug affordability review board. This legislation will be signed into law with several amendments introduced by our ecosystem. A strong coalition from our life sciences community made the changes possible.

We appreciate our community’s commitment to collaboration.

Jennifer Jones Paton
President & CEO
Colorado BioScience Association

Categories: CBSA News